ARCHIVES

Nexavar Improves PFS In HER-2 Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

President Accepts Rauscher Resignation

October 1, 1976

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

Bonner to Succeed Stovall as NCCS President and CEO.

May 30, 2008

In Brief: Breakthrough Prize Awarded to 11 Scientists

March 8, 2013

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

Final Issue Of the Year

December 14, 1990